Neural Biomarkers of Electroconvulsive Therapy Response
This study is looking at how electroconvulsive therapy (ECT) affects the brain's electrical activity and structure. Researchers will use special brain scans (fMRI and structural MRI) to understand these changes. You might be able to join if you are between 18 and 80 years old, have certain positive symptoms like hallucinations or unusual thoughts, and have not responded to at least one antipsychotic medication. The study will measure how much your symptoms improve using a scale called the Brief Psychiatric Rating Scale (BPRS) over 8 weeks. The current recruitment status is unclear.
- Study design
- This study will include 75 participants and will follow them over time to see how electroconvulsive therapy affects their brains and symptoms.
- What's involved
- You would have weekly monitoring with the Brief Psychiatric Rating Scale (BPRS) and undergo structural and functional MRI and MATRICS battery testing before and at the end of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed up until your 8th week of electroconvulsive therapy clinically, with primary and secondary measures taken at baseline and 8 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Neural Biomarkers of Electroconvulsive Therapy Response
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Miklos Argyelan, MD · PRINCIPAL_INVESTIGATOR · The Zucker Hillside Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Rate of Response to Brief Psychiatry Rating Scale (BPRS)Baseline and 8 weeks.
The change of total BPRS score between Week 8 and Baseline divided by baseline (percentage change). The change in the total score which can be between 18-126 (in extreme cases) will be reported.